Salix Pharmaceuticals, a New Jersey-based drug development company that focuses on gastrointestinal conditions, wants to get the bottom of what causes irritable bowel syndrome (IBS). To study the common condition– which affects some 25 to 45 million Americans – Salix has developed an interactive, virtual reality platform designed to give clinicians a gut feeling for what could be causing IBS. ...
